Overcoming the Technical Limitations of In Vivo Models for Constituting Human Neuroinflammatory Progression

Time: 4:00 pm
day: Conference Day Two


  • Critically analyzing the workflow of in vivo preclinical models and exploring additional models to put in place
  • Evaluating the translatability of in vivo models for neuroinflammatory targeting
  • Holistically assessing known effectors and targets that have yet to be deemed relevant in the neuroimmunology setting